Implantation of Resorbable Gentamicin Sponges in Addition to Irrigation and Debridement in 34 Patients with Infection Complicating Total Hip Arthroplasty
Restricted accessResearch articleFirst published online March, 2013
Implantation of Resorbable Gentamicin Sponges in Addition to Irrigation and Debridement in 34 Patients with Infection Complicating Total Hip Arthroplasty
We evaluated a prosthesis-retaining treatment protocol for prosthetic joint infection in patients presenting at a mean of 116 days (range 10-1216 days) after primary arthroplasty. Our regime involved irrigation and debridement followed by implantation of biodegradable gentamicin loaded sponges which do not require removal after implantation.
Of 34 patients with a deep infection after total hip arthroplasty, Twenty-five were treated successfully, with a mean follow-up of 35 months. There were no permanent complications. This success rate is comparable to earlier studies. Early initiation of treatment demonstrated a tendency for better results, and late chronic infections had a worse outcome. Because the sponges are degradable, a number of further surgical procedures were avoided.
ChenW.S., FuT.H., WangJ.W.Two-stage reimplantation of infected hip arthroplasties.Chang Gung Med J.2009; 32(2): 188–97.
6.
GiulieriS.G., GraberP., OchsnerP.E., ZimmerliW.Management of infection associated with total hip arthroplasty according to a treatment algorithm.Infection.2004; 32(4): 222–8.
7.
LanglaisF.Can we improve the results of revision arthroplasty for infected total hip replacement?J Bone Joint Surg Br.2003; 85(5): 637–40.
8.
SorianoA., GarciaS., BoriG.. Treatment of acute post-surgical infection of joint arthroplasty.Clin Microbiol Infect.2006; 12(9): 930–3.
9.
AboltinsC.A., PageM.A., BuisingK.L.. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.Clin Microbiol Infect.2007; 13(6): 586–91.
10.
WalenkampG.H.Joint prosthetic infections: a success story or a continuous concern?Acta Orthop.2009; 80(6): 629–32.
11.
ByrenI., BejonP., AtkinsB.L.. One hundred and twelve infected arthroplasties treated with 'DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome.J Antimicrob Chemother.2009; 63(6): 1264–71.
12.
CrockarellJ.R., HanssenA.D., OsmonD.R., MorreyB.F.Treatment of infection with debridement and retention of the components following hip arthroplasty.J Bone Joint Surg Am.1998; 80(9): 1306–13.
13.
KrasinE., GoldwirthM., HemoY., GoldA., HerlingG., OtremskiI.Could irrigation, debridement and antibiotic therapy cure an infection of a total hip arthroplasty?J Hosp Infect.2001; 47(3): 235–8.
14.
MarculescuC.E., BerbariE.F., HanssenA.D.. Outcome of prosthetic joint infections treated with debridement and retention of components.Clin Infect Dis.2006; 42(4): 471–8.
15.
MeehanA.M., OsmonD.R., DuffyM.C., HanssenA.D., KeatingM.R.Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis.Clin Infect Dis.2003; 36(7): 845–9.
16.
TrebseR., PisotV., TrampuzA.Treatment of infected retained implants.J Bone Joint Surg Br.2005; 87(2): 249–56.
17.
TsukayamaD.T., EstradaR., GustiloR.B.Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections.J Bone Joint Surg Am.1996; 78(4): 512–23.
18.
DiefenbeckM., MückleyT., HofmannG.O.Prophylaxis and treatment of implant-related infections by local application of antibiotics.Injury.2006; 37 Suppl 2: S95–104.
19.
RuszczakZ., FriessW.Collagen as a carrier for on-site delivery of antibacterial drugs.Adv Drug Deliv Rev.2003; 55(12): 1679–98.
20.
WalenkampG.H.Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review.J Chemother.2001; 13 Spec No 1(1): 66–72.
21.
NelsonC.L., EvansR.P., BlahaJ.D., CalhounJ., HenryS.L., PatzakisM.J.A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty.Clin Orthop Relat Res.1993; (295): 96–101.
22.
SwieringaA.J., GoosenJ.H., JansmanF.G., TulpN.J.In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: serum values in 19 patients.Acta Orthop.2008; 79(5): 637–42.
23.
WalenkampG.H., VreeT.B., van RensT.J.Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study.Clin Orthop Relat Res.1986; (205): 171–83.
24.
SalgadoC.D., DashS., CanteyJ.R., MarculescuC.E.Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections.Clin Orthop Relat Res.2007; 461: 48–53.
25.
ChoongP.F., DowseyM.M., CarrD., DaffyJ., StanleyP.Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen.Acta Orthop.2007; 78(6): 755–65.
26.
SharmaD., DouglasJ., CoulterC., WeinrauchP., CrawfordR.Microbiology of infected arthroplasty: implications for empiric peri-operative antibiotics.J Orthop Surg (Hong Kong).2008; 16(3): 339–42.
27.
HanssenA.D., SpangehlM.J.Treatment of the infected hip replacement.Clin Orthop Relat Res.2004; (420): 63–71.
28.
RodriguezD., PigrauC., EubaG.. Acute hematogenous prosthetic joint infection: prospective evaluation of medical and surgical management.Clin Microbiol Infect.2010; 16(12): 1789–95.
29.
GillespieW.J.Prevention and management of infection after total joint replacement.Clin Infect Dis.1997; 25(6): 1310–7.
30.
KaltsasD.S.Infection after total hip arthroplasty.Ann R Coll Surg Engl.2004; 86(4): 267–71.
